The effect of diphenyl-piperazine compounds and other agents on diphenylhydantoin, zoxazolamine and hexobarbital metabolism.
D000818:Animals; D001580:Benzopyrenes / Q000494:pharmacology; D003501:Cyclizine / Q000494:pharmacology; D003634:DDT / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D004721:Endoplasmic Reticulum / Q000187:drug effects; D006591:Hexobarbital / Q000378:metabolism*; D006801:Humans; D006919:Hydroxyzine / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects; D008297:Male; D008468:Meclizine / Q000494:pharmacology; D008748:Methylcholanthrene / Q000494:pharmacology; D051379:Mice; D008854:Microscopy, Electron; D010627:Phenethylamines / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000097:blood / Q000378:metabolism*; D010879:Piperazines / Q000494:pharmacology; D014268:Trifluoperazine / Q000494:pharmacology; D015049:Zoxazolamine / Q000378:metabolism*
D001580:Benzopyrenes; D010627:Phenethylamines; D010879:Piperazines; D014268:Trifluoperazine; D006919:Hydroxyzine; D008468:Meclizine; D008748:Methylcholanthrene; D010672:Phenytoin; D004155:Diphenhydramine; D015049:Zoxazolamine; D006591:Hexobarbital; D003634:DDT; D003501:Cyclizine; D010634:Phenobarbital